P. Hopwood

A. Howell, D. Evans, F. Lalloo, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Fictitious breast cancer family history

D. Evans, P. Hopwood, D. Cade, 1996, The Lancet.

A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.

A. Howell, D. Evans, F. Lalloo, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Psychological care of women with a family history of breast cancer

P. Hopwood, 2005 .

Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer

A. Howell, D. Evans, A. Shenton, 2001, Journal of medical genetics.

Comparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives

D. Craufurd, D. Evans, A. Shenton, 2009, Clinical genetics.

Hereditary Breast Cancer: Psychological Aspects of Counseling, Surveillance, and Management

P. Hopwood, 1997 .

Abstract S4-1: The UK START (Standardisation of Breast Radiotherapy) Trials: 10-year follow-up results

J. Yarnold, J. Dewar, P. Hoskin, 2012 .

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer

D. Girling, R. Stephens, N. Thatcher, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concerns, confiding and psychiatric disorder in newly diagnosed cancer patients: A descriptive study

R. Macleod, T. Ibbotson, P. Maguire, 1994 .

Z. Winters, P. Hopwood, R. Greenwood, 2009, The British journal of surgery.

OC-0595: FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy:3-year normal tissue effects

E. Sawyer, J. Yarnold, C. Coles, 2018 .

The British Prostate Group Autumn Meeting, 10–11 September 2001, Royal College of Surgeons, Lincoln's Inn Fields, London, UK

R. Eeles, S. Moss, A. Norman, 2002, Prostate Cancer and Prostatic Diseases.

Handbook of Psychooncology

P. Hopwood, A.-L B0rresen, J. C. Holland, 1993, British Journal of Cancer.

The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.

N. Aaronson, M. Groenvold, M. Sprangers, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience

P. Fayers, D. Girling, R. Stephens, 1997 .

Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001)

P. Ellis, D. Cameron, E. Hall, 2014, European journal of cancer.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Joanne S Haviland, John R Yarnold, J. Yarnold, 2013, The Lancet. Oncology.

Management of women with a family history of breast cancer in the North West Region of England: training for implementing a vision of the future

A. Howell, D. Evans, P. Hopwood, 2002, Journal of medical genetics.

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

J R Yarnold, J. Yarnold, J. Dewar, 2008, The Lancet.

Neurological and cognitive impairment in long-term survivors of small cell lung cancer.

A. Gregor, A. Cull, K. Stȩpniewska, 1994, European journal of cancer.

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

J. Yarnold, J. Haviland, J. Bliss, 2010, The Lancet. Oncology.

Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial

C. Woodman, C. Boggis, P. Hopwood, 2018 .

Clinical Guidelines and Evidence Report for The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care.

J. Emery, D. Easton, A. Mcintosh, 2004 .

Chemotherapy and quality of life in advanced NSCLC – reply

M. Nicolson, N. Thatcher, P. Hopwood, 2001, British Journal of Cancer.

Improving quality of life in patients with non-small cell lung cancer: research experience with gemcitabine.

N. Thatcher, P. Hopwood, H. Anderson, 1997, European journal of cancer.

Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial

D. Girling, R. Stephens, P. Hopwood, 2002, BMJ : British Medical Journal.

Risk reducing mastectomy: outcomes in 10 European centres

A. Howell, P. Møller, D. Eccles, 2008, Journal of Medical Genetics.

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.

A. Howell, D. Crowther, T. Dexter, 1989, British Journal of Cancer.

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

I. Ellis, M. Dowsett, P. Ellis, 2009, The Lancet.

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

E. Sawyer, J. Yarnold, C. Coles, 2020, The Lancet.

Abstract GS4-05: Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK/06/003)

J. Yarnold, C. Coles, M. Wilcox, 2019, General Session Abstracts.

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial

J. Yarnold, C. Coles, C. Kirwan, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

D. Girling, R. Stephens, D. Machin, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

False family history of breast cancer in the family cancer clinic.

D. Evans, S. Narod, C. Serruya, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Doxorubicin in advanced breast cancer: influence of schedule on response, survival and quality of life.

A. Howell, P. Hopwood, R. Swindell, 1992, European journal of cancer.

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party.

D. Machin, N. Bleehen, D. Girling, 1996, British Journal of Cancer.

Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review

O. Dalesio, H. Groen, M. Parmar, 2007, The Lancet.

Clinical Interpretation of Quality‐of‐Life Outcomes: An Investigation of Data from the Randomized Trial of Gemcitabine Plus Paclitaxel Compared with Paclitaxel Alone for Advanced Breast Cancer

P. Ellis, P. Hopwood, I. Smith, 2008, The breast journal.

Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires.

A. Howell, P. Maguire, P. Hopwood, 1991, British Journal of Cancer.

The impact of genetic counselling on risk perception in women with a family history of breast cancer.

A. Howell, D. Evans, P. Hopwood, 1994, British Journal of Cancer.

Perception of risk in women with a family history of breast cancer.

A. Howell, D. Evans, P. Hopwood, 1993, British Journal of Cancer.

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

J. Yarnold, J. Haviland, J. Bliss, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires.

A. Howell, P. Maguire, P. Hopwood, 1991, British Journal of Cancer.

CorrigendumCorrigendum to “The impact of age and clinical factors on quality of life in early breast cancer: An analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial)”: [Breast 16 (2007) 241–251]

J. Haviland, J. Bliss, J. Mills, 2008 .

Breast cancer risk perception: what do we know and understand?

P. Hopwood, Penelope Hopwood, 2000, Breast Cancer Research.

Priorities in the psychological care of cancer patients

P. Maguire, P. Hopwood, 1992 .

Single fraction prophylactic cranial irradiation for small cell carcinoma of the lung.

N. Thatcher, P. Hopwood, A. Brewster, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reply to Goodare et al. Re: Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy?

J. Yarnold, M. Wilcox, J. Haviland, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial

J. Yarnold, C. Coles, A. Kirby, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT)

I. Ellis, M. Dowsett, P. Ellis, 2009 .

Modelling the cost-effectiveness of first, second and third generation polychemotherapy regimens in women with early breast cancer who have differing prognoses.

M. Sculpher, H. Earl, J. Yarnold, 2009 .

Impact on quality of life (QoL) of FEC-T compared with FEC or E-CMF: UK Taxotere as Adjuvant Chemotherapy Trial (TACT) 2-year follow-up

D. Cameron, A. Ridolfi, E. Hall, 2008 .

Patients' views of distress & interference with daily activities due to side effects in the TACT (Taxotere as Adjuvant ChemoTherapy) trial

D. Cameron, A. Ridolfi, E. Hall, 2008 .

Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer.

P. Barber, P. Hopwood, R. Swindell, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

E. Sawyer, J. Yarnold, C. Coles, 2023, The Lancet.

A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.

N. Thatcher, P. Hopwood, H. Anderson, 1993, British Journal of Cancer.

Re: risk-reduction mastectomy: clinical issues and research needs.

A. Howell, D. Evans, F. Lalloo, 2002, Journal of the National Cancer Institute.

Treatment of depression in cancer patients

N. Tarrier, P. Maguire, P. Hopwood, 1985, Acta psychiatrica Scandinavica. Supplementum.

Antidepressant medications in cancer patients

P. Maguire, P. Hopwood, S. Chaturvedi, 1994 .

OC-0135 CAN PATIENT REPORTED OUTCOME MEASURES REPLACE CLINICAL ASSESSMENTS IN BREAST RADIOTHERAPY TRIALS?

J. Yarnold, J. Haviland, J. Bliss, 2012 .

Hypofractionation for early breast cancer: First results of the UK standardization of breast radiotherapy (START) trials

J. Yarnold, J. Dewar, J. Haviland, 2007 .

Treatment of endotracheal or endobronchial obstruction by non-small cell lung cancer: lack of patients in an MRC randomized trial leaves key questions unanswered. Medical Research Council Lung Cancer Working Party.

R. Stephens, D. Girling, K. Moghissi, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

506 Clinically relevant quality of life outcomes in the first UK randomised trial of endobronchial brachytherapy (EBT) versus external beam radiotherapy (XRT) in patients with inoperable non-small cell cancer (NSCLC)

P. Barber, P. Hopwood, R. Swindell, 1997 .

Impact of pre-operative chemotherapy on the quality of life (QL) of patients with resectable non-small cell lung cancer (NSCLC): Experience from the MRC LU22/NVALT/EORTC 08012 multicentre randomised trial

R. Stephens, M. Nankivell, M. Nicolson, 2007 .

Impact on quality of life (QL) during chemotherapy (CT) of FEC-T compared to FEC or E-CMF: Results from the UK NCRI Taxotere as Adjuvant Chemotherapy Trial (TACT)

D. Cameron, E. Hall, J. Bliss, 2005 .

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial

E. Sawyer, J. Yarnold, C. Coles, 2023, The Lancet.

Immediate versus delayed thoracic radiotherapy (TRT) in patients with unresectable, locally advanced non-small cell lung cancer (NSCLC) and minimal symptoms: Results of an MRC/BTS randomised trial

D. Girling, P. Hopwood, W. Qian, 2000 .

Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET).

D. Cameron, J. Dixon, P. Hopwood, 2004, Breast.

Marsupial stress syndrome.

P. Hopwood, S. King, 1972, Australian Veterinary Journal.